my account
log out
|
|
my account
log out
|
Anti-GRM2 VHH |
| Create: 01/11/2017 |
| Expired Date: | 01/02/2018 |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | The anti-metabotropic glutamate receptor subtype 2 (mGluR2) conformational single domain antibody target mGluR2 which contribute to the fine-tuning of synaptic efficacy. The llama-derived anti-mGluR2 single domain antibody act as a positive allosteric modulator and are able to stabilized the active state of mGluR2. Therefore, the anti-mGluR2 single domain antibody can be useful in the treatment of schizophrenia, epilepsy, addiction/drug dependence, Parkinson's disease, pain, sleep disorders and Huntington's disease. |
| City: | Shirley[US]
 |
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 271 | |
| Feb 01 2023 | GVBE Buffer | 278 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 278 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 274 | |
| Aug 30 2019 |  | Anti-HSV-2 gH Antibody | 464 |
| Aug 30 2019 | | Anti-L. major LPG Antibody | 545 |
| Aug 30 2019 | | Anti-DENV-1 Antibody | 453 |
| Aug 30 2019 | | Anti-BPV-1 L1 Antibody | 468 |
| Aug 30 2019 | | Anti-H3N2 HA Antibody | 456 |
| Aug 30 2019 | | Anti-EIAV env Antibody | 477 |
| Copyright © toextrade Inc. All rights reserved. Contact us |